- arrested T cell differentiation / MGI
- abnormal double-negative T cell morphology / MGI
- abnormal B cell morphology / MGI
- abnormal regulatory T cell physiology / MGI
- absent T cells / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- absent CD8-positive, alpha-beta T cells / MGI
- absent CD4-positive, alpha beta T cells / MGI
B6.Cg-Cd3etm1Mal Prss16tm1.1Mal/Cnbc
| Status | Available to order |
| EMMA ID | EM:08270 |
| Citation information | RRID:IMSR_EM:08270 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | B6.Cg-Cd3etm1Mal Prss16tm1.1Mal/Cnbc |
| Alternative name | TSSP KO CD3E KO |
| Strain type | Targeted Mutant Strains : Knock-out |
| Allele/Transgene symbol | Cd3etm1Mal, Prss16tm1.1Mal |
| Gene/Transgene symbol | Cd3e, Prss16 |
Information from provider
| Provider | Alice Carrier |
| Provider affiliation | Stress Cell, CRCM |
| Additional owner | Dr. Marie Malissen, Centre d'Immunologie de Marseille-Luminy (CIML), France |
| Genetic information | Deletion of Prss16 gene encoding thymus-specific serine protease (TSSP), on a CD3epsilon-deficient background. |
| Phenotypic information | Homozygous:Partial immunodeficiency (altered repertoire of CD4 T cells).Heterozygous:No phenotype |
| Breeding history | We already described the breeding history in our previous submission of this Prss16 knock-out on C57BL/6 and 129/Sv background (EMMA strain ID EM:01380). For the present submission on CD3epsilon-deficient background, we have crossed homozygous Prss16 knock-out on C57BL/6 background with CD3epsilon delta5 mice (EMMA strain ID EM:00047) provided by Marie Malissen (CIML, France). The resulting double knock-out mice are mandatory for T cells adoptive transfer experiments. |
| References |
|
| Homozygous fertile | yes |
| Homozygous viable | yes |
| Homozygous matings required | yes |
| Immunocompromised | yes |
Information from EMMA
| Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
| Animals used for archiving | homozygous C57BL/6 males, homozygous C57BL/6 females |
| Stage of embryos | 2-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta / Orphanet_169160
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- abnormal thymus morphology / MGI
- small thymus / MGI
- absent CD8-positive, alpha-beta T cells / MGI
- thymus hypoplasia / MGI
- arrested T cell differentiation / MGI
- seizures / MGI
- abnormal T cell differentiation / MGI
- abnormal double-negative T cell morphology / MGI
- abnormal double-positive T cell morphology / MGI
- absent CD4-positive, alpha beta T cells / MGI
- abnormal class switch recombination / MGI
- abnormal B cell morphology / MGI
- abnormal regulatory T cell physiology / MGI
- increased double-negative T cell number / MGI
- decreased double-positive T cell number / MGI
- abnormal T cell number / MGI
- increased T cell apoptosis / MGI
- abnormal T cell morphology / MGI
- absent T cells / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- increased DN3 thymocyte number / MGI
- no abnormal phenotype detected / MGI
- abnormal thymus cortex morphology / MGI
- immune system phenotype / MGI
- abnormal professional antigen presenting cell morphology / MGI
Literature references
- Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes.;Gommeaux Julien, Grégoire Claude, Nguessan Prudence, Richelme Mireille, Malissen Marie, Guerder Sylvie, Malissen Bernard, Carrier Alice, ;2009;European journal of immunology;39;956-64; 19283781
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
